Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients - The New England Journal of Medicine. 2000
Brief Summary:
Ramipril reduces rates of death, MI, and stroke among patients with multiple CV risk factors and without heart failure.Reference: http://www.ncbi.nlm.nih.gov/pubmed/10639539
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you